« back


Dermot McGovern, M.D., Ph.D., a co-founder of Prometheus Biosciences, is the Director of Translational Medicine at the F. Widjaja Foundation Imflammatory Bowel and Immunobiology Research Institute at Cedars-Sinai and also directs the Cedars-Sinai Precision Medicine Initiative.  He holds the Joshua and Lisa Greer Endowed Chair in IBD Genetics.  He serves on the National Scientific Advisory Committee for the Crohn’s and Colitis Foundation as well as the steering committees of the National and International IBD Genetics Consortia. He and his colleagues have published approximately 150 peer-reviewed papers in medical journals.